Pharmaceutical giant GlaxoSmithKline is selling its thrombosis brands, together with the Notre-Dame de Bondeville manufacturing site in France, to South Africa-based Aspen Pharmacare for $1.13 billion.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304373104579106950323338252.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304373104579106950323338252.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento